2 research outputs found

    Additional file 1 of Prioritization of therapeutic targets for cancers using integrative multi-omics analysis

    No full text
    Additional file 1. Table S1. The information of outcomes resources. Table S2. The information of exposures resources. Table S3. The information of TWAS-significant genes in whole blood. Table S4. Results of SMR for genes associated with cancers in whole blood. Table S5. Results of colocalization for the genes signficantly associated wtith cancers in TWAS and SMR analysis in whole blood. Table S6. The information of TWAS-significant genes in specific organ tissues. Table S7. Results of SMR for genes associated with cancers in specific organ tissues. Table S8. Results of colocalization for the genes signficantly associated wtith cancers in TWAS and SMR analysis in specific organ tissues. Table S9. The information of PWAS-significant genes in whole blood. Table S10. Results of MR for protein-code genes associated with cancers in whole blood. Table S11. Results of colocalization for protein-code genes signficantly associated wtith cancers in PWAS and MR analysis in whole blood. Table S12. The list of druggable genes for SMR.  Table S13. Results of SMR for druggable genes associated with cancers. Table S14. Results of colocalization for identified druggable genes wtith cancers in FinnGen cohort. Table S15. Results of phenotype scanning on candidate genes. Table S16. The information of enrichment analysis for candidate genes. Table S17. Results of enrichment analysis for candidate genes. Table S18. The information of metabolic pathways. Table S19. The information of IVs for Metabolome-wide Mendelian Randomization on cancers. Table S20. Results of Metabolome-Wide Mendelian Randomization on cancers
    corecore